reddys fonda sales

North America generic sales increased 76% for Reddys in the last Quarter. Quoting Business Standard, Reddys had strong growth with injectables and named Fonda as a strong contributor. The question is how much to ACL. Anything less than AUD 4.3 m , I would have to be asking serious questions. My calcs are based on improved COGS, increased market share of 4 or 5 % and the devalued AUD since the last Qtr. in fact I'm hoping its 4.5 mill to ACL.